Himax orders will surge as VR and AR take hold: Exelixis (EXEL) rebounded from around $18 - $20 to $24.64 a share. EXEL was in the doghouse. $EXEL, Exelixis, Inc. / D Acadia Pharmaceuticals (ACAD) bottomed at $25. Oversold condition gave way to buying. Teva Pharma (TEVA) was too cheap below $30. Sarepta (SRPT) multiple bottom was at $27 - $30. The incoming CEO could lead to Allergan buying SRPT. Alibaba (BABA) breezed past the $130 PT and closed at ~ $140. Himax Technology (HIMX) bottomed. The rally through to $8.50 stalled. HIMX is also a DIY Top Idea. $HIMX, Himax Technologies, Inc. / D Micron (MU) did not quite close at $35 when it reported earnings. Trading action on MU was covered throughout the week for DIY Investing Subscribers. Snap Inc. (SNAP) fell below $15. Short SNAP, Long TWTR, Long FB is a viable strategy. Valeant (VRX) breezed past the PT $15. Thanks, CEO Joe Papa. $BHC, Bausch Health Companies Inc. / D Citi (C) was pumping Nvidia (NVDA). If you had $25,000 for Investing,You would Buy ___- the most popular post in June. Goldman (GS) is downgrading AMD (AMD). Speculate it is doing so to get a better entry price. $AMD, Advanced Micro Devices, Inc. / D Rite Aid (RAD) management fleeced shareholders and bondholders. Well-played. Walgreens (WBA) did a fine job getting this deal through (pending FTC approval). Looking ahead:July’s top 3 biotech picks are here. VRX is on the list. Value Stocks milestone: 700 members. Post your trading move below. Sign-in now (via StockTwits, Facebook, Twitter). ‘Like’ this post to <<ping>> all followers.